Despite a 7% sales decline due to currency impacts, Vitrolife AB (VTRLY) reports strong organic growth in key regions and strategic advancements in IVF technology.
Vitrolife AB (VTRLY) Q2 2025 Earnings Call Highlights: Navigating Currency Challenges and …
view original post